{
  "9384756_syn_1": "Proc: EBUS + EMN + TBBx.\nEBUS: Stations 5, 7, 10L sampled (31653). N2/N3 positive.\nNav: EMN to LUL mass. Radial EBUS confirmed (31627, 31654).\nSampling: TBBx (31628), Brush, Needle. Endobronchial bx of anterior segment (31625). BAL (31624).\nDx: Stage IIIB Squamous Cell.",
  "9384756_syn_2": "OPERATIVE REPORT: Combined EBUS Staging and Electromagnetic Navigation.\nMediastinal staging via EBUS-TBNA of stations 5, 7, and 10L confirmed N2/N3 disease. Following this, electromagnetic navigation with radial EBUS verification was utilized to localize the peripheral LUL mass. Transbronchial biopsies were obtained. Additionally, endobronchial forceps biopsies were taken from a visible lesion in the anterior segment. Bronchoalveolar lavage was performed. Rapid pathology confirmed squamous cell carcinoma.",
  "9384756_syn_3": "Coding Summary:\n- 31653: EBUS sampling 3 stations (5, 7, 10L).\n- 31627: Navigation Add-on.\n- 31654: Radial EBUS Add-on.\n- 31628: Transbronchial Biopsy (LUL Mass).\n- 31625: Endobronchial Biopsy (Distinct lesion anterior segment).\n- 31624: BAL.\nDx: Squamous Cell CA.",
  "9384756_syn_4": "Procedure: EBUS/Nav Bronch\nPt: [REDACTED]\nSteps:\n1. EBUS: Sampled 5, 7, 10L. Positive.\n2. Switched scopes.\n3. Navigated to LUL mass. Confirmed w/ Radial EBUS.\n4. Biopsied mass (TBBx).\n5. Saw tumor in airway, biopsied that too (Endobronchial).\n6. BAL.\nPlan: Chemo/Rad.",
  "9384756_syn_5": "bronchoscopy note for kenji nakamura... big case... started with ebus sampled stations 5 7 and 10L rose called it squamous... then did the superdimension navigation to the lul mass found it with radial probe... took biopsy brush needle... also saw tumor sticking out in the anterior segment biopsied that directly... did a wash too... patient has stage 3b cancer.",
  "9384756_syn_6": "EBUS-TBNA of mediastinal/hilar lymph nodes. Electromagnetic navigation bronchoscopy. Radial EBUS. Transbronchial biopsy of LUL mass. Station 5: Sampled. Station 7: Sampled. Station 10L: Sampled. EMN Navigation: Target LUL mass. Radial EBUS: Lesion >35mm. Sampling via guide sheath: Forceps biopsies, Brush cytology, Needle aspiration. Direct endobronchial biopsies: 4 specimens. ROSE: Squamous cell carcinoma confirmed. Stage IIIB.",
  "9384756_syn_7": "[Indication]\nLUL Mass, Staging.\n[Anesthesia]\nMAC.\n[Description]\n1. EBUS-TBNA: Stations 5, 7, 10L (Positive).\n2. EMN/REBUS: Localized LUL mass.\n3. Sampling: TBBx, needle, brush of mass. BAL.\n4. Endobronchial Bx: Anterior segment lesion.\n[Plan]\nOncology consult.",
  "9384756_syn_8": "Kenji underwent a complex bronchoscopy for a large lung mass. First, we used EBUS to sample lymph nodes in the AP window, subcarinal, and hilar areas; all showed cancer. We then used electromagnetic navigation and radial ultrasound to find the main tumor deep in the lung and biopsied it. We also noticed tumor tissue growing into the airway and biopsied that separately. The wash and biopsies confirmed squamous cell carcinoma.",
  "9384756_syn_9": "Procedure: Multimodal Bronchoscopic Staging and Diagnosis.\nAction: Performed ultrasonic needle aspiration of 3 nodal stations. Navigated to peripheral lesion utilizing electromagnetic guidance and radial ultrasound. Acquired parenchymal tissue (transbronchial). Acquired endoluminal tissue (endobronchial). Performed lavage.\nResult: Diagnosed Squamous Cell Carcinoma.",
  "9384756": "BRONCHOSCOPY NOTE - COMBINED EBUS + EMN\n\nUniversity Hospital Bronchoscopy Suite\n\n**PT:** Nakamura, Kenji | 67M | MRN [REDACTED]\n**DATE:** [REDACTED]\n**PHYSICIANS:** Dr. Sarah Williams (Attending), Dr. Marcus Johnson (Fellow)\n**ANESTHESIA:** MAC team - Dr. Lisa Park\n\n**INDICATION:**\nLUL mass 4.2cm + mediastinal adenopathy. Staging and tissue diagnosis needed.\n\n**PROCEDURES:**\n- EBUS-TBNA of mediastinal/hilar lymph nodes\n- Electromagnetic navigation bronchoscopy\n- Radial EBUS\n- Transbronchial biopsy of LUL mass\n\n**CLINICAL CONTEXT:**\nPatient [REDACTED] 50 py smoking history, now [REDACTED] large LUL mass crossing fissure. PET shows: primary lesion SUV 11.3, station 5 (AP window) 2.4cm SUV 6.7, station 7 1.9cm SUV 5.2, station 10L 1.6cm SUV 4.8. Need staging before treatment planning.\n\n**MEDICATIONS/ANESTHESIA:**\nModerate-deep sedation. Propofol infusion (bolus 200mg, then 75-150 mcg/kg/min). Fentanyl 125mcg IV. Patient maintained spontaneous respirations [REDACTED] supplemental O2 via NC.\n\n**PART 1 - EBUS EXAMINATION:**\n\nEBUS scope (Olympus) inserted through mouth.\n\nLYMPH NODE SURVEY:\n\n*Station 2R:* 8mm - not sampled (too small)\n\n*Station 4R:* 11mm - appears reactive, not sampled\n\n*Station 4L:* 14mm - appears reactive, not sampled\n\n*Station 5 (AP window):*\n- Measured: 24mm x 18mm\n- Echo: Hypoechoic, heterogeneous\n- Shape: Oval [REDACTED] irregular borders\n- Blood flow: Present on Doppler\n- **Sampled: 22G needle x 5 passes**\n- ROSE: \"Positive for malignancy, NSCLC\"\n\n*Station 7 (subcarinal):*\n- Measured: 18mm x 15mm\n- Echo: Hypoechoic, fairly homogeneous\n- **Sampled: 22G needle x 4 passes**\n- ROSE: \"Positive for malignancy, similar to station 5\"\n\n*Station 10L (left hilar):*\n- Measured: 15mm x 12mm\n- Echo: Hypoechoic\n- **Sampled: 22G needle x 3 passes**\n- ROSE: \"Positive for malignancy\"\n\n*Station 11L:* Not well-visualized on EBUS\n\n**PART 2 - EMN BRONCHOSCOPY OF PRIMARY TUMOR:**\n\nEBUS scope removed. Standard therapeutic bronchoscope (Olympus BF-1TH190) inserted.\n\nInitial airway survey:\n- Trachea: patent, no extrinsic compression\n- Carina: sharp\n- LUL orifice: partially narrowed by external compression from mass\n- LUL segments: able to pass scope, but narrowed\n- Remainder of left and right bronchial tree: patent\n\n**EMN Navigation:**\nSuperDimension system used. CT from [REDACTED] uploaded.\n\nTarget: LUL mass (posterior segment component - anterior component has endobronchial extension)\n\nRegistration: Automatic + manual verification. 8 points confirmed. System accuracy indicator >90%.\n\nLocatable guide advanced to LUL posterior segment. Navigation suggested tool within 9mm of target center.\n\n**Radial EBUS:**\n- Pattern: Concentric initially, then lost signal (likely probe too close to chest wall/fissure)\n- Repositioned catheter 8mm proximally\n- New pattern: Eccentric but visualizing lesion\n- Lesion: Very heterogeneous, areas of necrosis likely present\n- Size by ultrasound: >35mm\n\n**Sampling via guide sheath:**\n- Forceps biopsies: 9 specimens (some friable, concerning for necrosis)\n- Brush cytology: 4 passes\n- Needle aspiration: 21G needle, 3 passes\n- BAL: 80cc in, 35cc returned\n\n**ROSE (Primary Tumor):**\n\"Adequate sample. Malignant cells present. Poorly differentiated carcinoma, likely squamous cell carcinoma based on cytologic features. Differs from adenocarcinoma pattern sometimes seen - recommend awaiting permanent sections for final classification.\"\n\n**ADDITIONAL SAMPLING - ENDOBRONCHIAL COMPONENT:**\n\nReturned to LUL orifice. Visible endobronchial tumor on anterior segment ostium.\n\nDirect endobronchial biopsies: 4 specimens using standard forceps.\n\nROSE: \"Squamous cell carcinoma confirmed\"\n\nMinimal bleeding from endobronchial biopsy site. Resolved [REDACTED] gentle suction.\n\n**COMPLETION:**\n\nTotal procedure time: 67 minutes\n\nPatient [REDACTED]. No complications. Extubated to room air. Stable.\n\n**EBL:** ~15mL\n\n**SPECIMENS:**\n1. Station 5 TBNA x5\n2. Station 7 TBNA x4\n3. Station 10L TBNA x3\n4. LUL mass TBBx x9 (via EMN)\n5. LUL mass brushings x4\n6. LUL mass needle aspirate x3\n7. LUL mass BAL\n8. LUL endobronchial tumor biopsies x4\n\n**ROSE SUMMARY:**\n- N2 disease present (stations 5, 7)\n- N1 disease present (station 10L)\n- Primary tumor: Squamous cell carcinoma\n\n**IMPRESSION:**\nStage IIIB squamous cell carcinoma of LUL (T3-4 given size/fissure involvement, N2-3, M0). Not surgical candidate. Needs definitive chemoradiation vs clinical trial.\n\n**PLAN:**\n- Brain MRI for staging\n- Tumor board discussion\n- Medical onc + radiation onc consults\n- F/u IP clinic 1 week\n\nCXR ordered post-procedure - prelim read shows no PTX.\n\nDr. Sarah Williams - attending, present throughout"
}
